recombinant VSV vector-based Ebola/Marburg vaccine (Emergent Biosolutions)

N/A

Report date: 2025/03/20 09:12:49

Base Information

Drug Namerecombinant VSV vector-based Ebola/Marburg vaccine (Emergent Biosolutions)

Drug Alias NamerVSV Ebola/Marburg vaccine (Profectus BioSciences)rVSVN4CT1 Ebola/Marburg vaccine (Profectus BioSciences)recombinant VSV vector-based Ebola/Marburg vaccine (Profectus BioSciences)recombinant vesicular stomatitis virus vector-based Ebola/Marburg vaccine (Profectus BioSciences)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc

Inactive CompaniesAuro Vaccines Llc +[2]

Active IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Inactive IndicationsN/A

Other Information

ATC CodeN/A